- Home
- AGX vs RNA Comparison
AGX vs RNA Comparison
Compare AGX & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGX
- RNA
- Stock Information
- Founded
- AGX 1961
- RNA 2012
- Country
- AGX United States
- RNA United States
- Employees
- AGX N/A
- RNA N/A
- Industry
- AGX Engineering & Construction
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- AGX Consumer Discretionary
- RNA Health Care
- Exchange
- AGX Nasdaq
- RNA Nasdaq
- Market Cap
- AGX 3.7B
- RNA 4.0B
- IPO Year
- AGX N/A
- RNA 2020
- Fundamental
- Price
- AGX $281.46
- RNA $48.44
- Analyst Decision
- AGX Buy
- RNA Strong Buy
- Analyst Count
- AGX 4
- RNA 17
- Target Price
- AGX $220.25
- RNA $69.53
- AVG Volume (30 Days)
- AGX 314.4K
- RNA 3.4M
- Earning Date
- AGX 09-04-2025
- RNA 11-06-2025
- Dividend Yield
- AGX 0.53%
- RNA N/A
- EPS Growth
- AGX 160.19
- RNA N/A
- EPS
- AGX 8.31
- RNA N/A
- Revenue
- AGX $920,885,000.00
- RNA $10,729,000.00
- Revenue This Year
- AGX $11.84
- RNA N/A
- Revenue Next Year
- AGX $20.79
- RNA $108.74
- P/E Ratio
- AGX $33.90
- RNA N/A
- Revenue Growth
- AGX 29.16
- RNA 1.23
- 52 Week Low
- AGX $101.02
- RNA $21.51
- 52 Week High
- AGX $283.35
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- AGX 60.98
- RNA 60.32
- Support Level
- AGX $259.41
- RNA $38.94
- Resistance Level
- AGX $283.35
- RNA $47.96
- Average True Range (ATR)
- AGX 11.50
- RNA 2.19
- MACD
- AGX -0.26
- RNA 0.54
- Stochastic Oscillator
- AGX 72.20
- RNA 97.67
About AGX Argan Inc.
Argan Inc is a United States-based construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC, and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Telecom Services, out of which Power Services derives the majority of revenue.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.